<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05018325</url>
  </required_header>
  <id_info>
    <org_study_id>202103025</org_study_id>
    <nct_id>NCT05018325</nct_id>
  </id_info>
  <brief_title>Assessing Effect of Withdrawal Time on Adenoma Detection Rate for Screening Colonoscopy</brief_title>
  <official_title>Assessing Effect of Withdrawal Time on Adenoma Detection Rate for Screening Colonoscopy: A Randomized Tandem Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators' null hypothesis is that a withdrawal time of 9 to 10 minutes is&#xD;
      non-inferior to a withdrawal time of 12 minutes or greater. Thus, the goal of this tandem&#xD;
      design trial is to compare the additional diagnostic yield (# of missed lesions) for&#xD;
      withdrawal times exceeding 10 minutes for screening/surveillance colonoscopies. Although&#xD;
      withdrawal times longer than the standard 6-minute recommendation have been shown to be&#xD;
      beneficial, there is limited prospective evidence investigating the benefit or lack thereof&#xD;
      for withdrawal times greater than 9-10 minutes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 30, 2021</start_date>
  <completion_date type="Anticipated">August 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Miss rate of polyps</measure>
    <time_frame>Time of colonoscopy (day 1)</time_frame>
    <description>Miss rate = missed polyps/missed polyps + polyps found during 1st exam&#xD;
Polyps is defined as adenomas and sessile serrated adenomas (SSA)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Miss rate of advanced adenomas</measure>
    <time_frame>Time of colonoscopy (day 1)</time_frame>
    <description>Miss rate = missed advanced adenomas/missed advanced adenomas + advanced adenomas found during 1st exam&#xD;
Advanced adenoma defined as a polyp â‰¥ 10mm, adenomas with high-grade dysplasia or villous architecture, serrated lesions with dysplasia, or traditional serrated adenomas</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">270</enrollment>
  <condition>Colon Cancer</condition>
  <condition>Rectal Cancer</condition>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Arm 1: Colonoscopy 6 minute withdrawal time</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>-Undergo colonoscopy with the standard 6-minute withdrawal time followed by a tandem colonoscopy of at least another 6-minute withdrawal time.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2: Colonoscopy 9 minute withdrawal time</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>-Undergo a 9-minute withdrawal time followed by a tandem colonoscopy with at least the standard 6-minute withdrawal time.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 3: Colonoscopy 12 minute withdrawal time</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>-Undergo colonoscopy with a 12-minute withdrawal time followed by a tandem colonoscopy with at least the standard 6-minute withdrawal time</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Colonoscopy with 6 minute withdrawal</intervention_name>
    <description>Withdrawal time will be determined using a digital stopwatch by the nursing staff.</description>
    <arm_group_label>Arm 1: Colonoscopy 6 minute withdrawal time</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Colonoscopy 9 minute withdrawal</intervention_name>
    <description>Withdrawal time will be determined using a digital stopwatch by the nursing staff.</description>
    <arm_group_label>Arm 2: Colonoscopy 9 minute withdrawal time</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Colonoscopy 12 minute withdrawal</intervention_name>
    <description>Withdrawal time will be determined using a digital stopwatch by the nursing staff.</description>
    <arm_group_label>Arm 3: Colonoscopy 12 minute withdrawal time</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Must be between the ages of 18 and 75 years&#xD;
&#xD;
          -  Must be a patient undergoing screening or surveillance colonoscopy&#xD;
&#xD;
          -  Must be able to understand and willing to sign an IRB-approved written informed&#xD;
             consent document.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to provide informed consent.&#xD;
&#xD;
          -  Personal history of colorectal cancer (CRC)&#xD;
&#xD;
          -  Personal history of colon surgery or colon resection&#xD;
&#xD;
          -  Personal history of Inflammatory bowel disease&#xD;
&#xD;
          -  Personal history of familial polyposis&#xD;
&#xD;
          -  Current pregnancy&#xD;
&#xD;
          -  Active GI bleeding&#xD;
&#xD;
          -  Colonoscopy exams where the cecum cannot be reached (randomization will occur after&#xD;
             cecum is reached).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vladimir Kushnir, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vladimir M Kushnir, M.D.</last_name>
    <phone>314-454-5960</phone>
    <email>vkushnir@wustl.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thomas Hollander, R.N.</last_name>
    <phone>314-747-1973</phone>
    <email>hollandert@wustl.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vladimir M Kushnir, M.D.</last_name>
      <phone>314-454-5960</phone>
      <email>vkushnir@wustl.edu</email>
    </contact>
    <contact_backup>
      <last_name>Thomas Hollander, R.N.</last_name>
      <phone>314-747-1973</phone>
      <email>hollandert@wustl.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Vladimir M Kushnir, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cassandra Fritz, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dayna Early, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.siteman.wustl.edu</url>
    <description>Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine</description>
  </link>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 12, 2021</study_first_submitted>
  <study_first_submitted_qc>August 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 24, 2021</study_first_posted>
  <last_update_submitted>September 20, 2021</last_update_submitted>
  <last_update_submitted_qc>September 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data that underline the results reported, after deidentification.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Immediately following publication without an end date</ipd_time_frame>
    <ipd_access_criteria>Anyone who wishes to access the data.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

